Stock 1177 SINO BIOPHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 06:28:23 30/04/2024 BST 		5-day change 1st Jan Change
2.71 HKD -3.56% Intraday chart for Sino Biopharmaceutical Limited +5.04% -21.90%
04-25 Sino Biopharm Completes Phase I Study of Hepatitis B Drug MT
04-22 Lull in Geopolitical Tensions Lifts Asian Stock Markets MT

Business Summary

Sino Biopharmaceutical Limited specialises in the development, manufacture and marketing of biopharmaceutical products primarily for the treatment of cancer, ophthalmia, hepatitis, orthopedic diseases and respiratory disorders. Net sales break down by category of products as follows:

- chemical medicine products and biopharmaceutical drugs (97.6%);

- other (2.4%).

Number of employees: 25,806

Sales per Business

HKD in Million2021Weight2022Weight Delta
Modernised Chinese Medicines and Chemical Medicines
98.1 %
31,613 97.7 % 32,830 98.1 % +3.85%
Others
1.9 %
760 2.3 % 638 1.9 % -16.05%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
32,374 100.0 % 33,468 100.0 % +3.38%

Managers

Managers TitleAgeSince
S Y Tse CEO
 Chief Executive Officer 29 22/10/19
Ping Tse FOU
 Founder 72 01/02/00
Chun Ling Li DFI
 Director of Finance/CFO 53 -
Ming Qin Li BRD
 Director/Board Member 66 28/02/97
Hsin Tse BRD
 Director/Board Member 54 31/07/95
Sean Chen PRN
 Corporate Officer/Principal 46 31/12/21
Qian Li PRN
 Corporate Officer/Principal - 31/05/09
Philip Duong PRN
 Corporate Officer/Principal 34 31/12/19
Benjamin Toogood PRN
 Corporate Officer/Principal 48 31/12/20
Oi Nin Chan SEC
 Corporate Secretary 56 24/08/15

Members of the board

Members of the board TitleAgeSince
Ping Tse FOU
 Founder 72 01/02/00
Cheung Ling Cheng BRD
 Director/Board Member 60 31/12/04
Hsin Tse BRD
 Director/Board Member 54 31/07/95
Da Kui Li BRD
 Director/Board Member 80 31/08/04
Ming Qin Li BRD
 Director/Board Member 66 28/02/97
Lu Fu Zhang BRD
 Director/Board Member 67 19/04/15
Hong Lu BRD
 Director/Board Member 55 19/04/15
Theresa Tse CHM
 Chairman 32 29/06/15
Kwok Tung Li BRD
 Director/Board Member 69 30/12/20
S Y Tse CEO
 Chief Executive Officer 29 22/10/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,801,217,230 9,740,976,595 ( 51.81 %) 0 51.81 %

Shareholders

NameEquities%Valuation
S Y Tse
21.57 %
4,055,000,000 21.57 % 1 565 M $
Cheung Ling Cheng
15.79 %
2,968,678,124 15.79 % 1 146 M $
Ping Tse
8.897 %
1,672,704,241 8.897 % 645 M $
Hsin Tse
0.9268 %
174,247,000 0.9268 % 67 M $
Bosera Asset Management Co., Ltd.
0.4681 %
88,013,000 0.4681 % 34 M $
China Asset Management Co., Ltd.
0.2558 %
48,085,900 0.2558 % 19 M $
OrbiMed Advisors Private Equity
0.2215 %
41,653,000 0.2215 % 16 M $
State Street Global Advisors Ltd.
0.1303 %
24,506,016 0.1303 % 9 M $
Pension Reserves Investment Management Board
0.1213 %
22,802,540 0.1213 % 9 M $
Goldman Sachs Asia LLC (Investment Management)
0.1175 %
22,096,500 0.1175 % 9 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000942 %
8,855 0.000942 % 68 334 $

Holdings

NameEquities%Valuation
SHANDONG BOAN BIOTECHNOLOGY CO., LTD.
0.27%
 1,376,000 0.27% 1,775,728 $

Company contact information

Sino Biopharmaceutical Ltd.

Unit 09, 41st Floor, Office Tower Convention Plaza

, Hong Kong

+852 2802 9886

http://www.sinobiopharm.com
address Sino Biopharmaceutical Limited(1177)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Sino Biopharmaceutical Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
2.599 CNY
Average target price
4.32 CNY
Spread / Average Target
+66.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SINO BIOPHARMACEUTICAL LIMITED Stock Sino Biopharmaceutical Limited
-19.02% 6.49B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 332B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.04% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1177 Stock
  4. Company Sino Biopharmaceutical Limited